MetaCap

Beta Bionics (BBNX) vs Lumexa Imaging (LMRI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

Lumexa Imaging is the larger company by market cap ($1.01 billion vs $951.1 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBNX-39.85%LMRI-43.09%
+13%-30%-74%
Dec 11, 20251 yearOct 9, 2026
BBNX-41.43%LMRI-43.12%
+11%-32%-74%
Dec 8, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBNX versus LMRI key metrics
MetricBBNXLMRI
Share price$17.63$10.54
Market cap$951.07M$1.01B
1-day change+1.15%+2.03%
YTD return-42.14%-43.03%
1-year return-20.69%—
Forward P/E—11.84
EPS (TTM)$-1.66$-0.37
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$100.25M—
Revenue growth (YoY)+53.94%—
Net income (latest FY)$-73.20M—
Gross margin55.40%—
Operating margin-71.50%—
Net margin-73.02%—
52-week high$32.71$19.45
52-week low$8.80$6.45
Distance from 52-week high-46.10%-45.81%
Analyst consensusbuystrong_buy
Avg. price target upside+35.00%+67.65%
Average volume1.31M430.76K
Shares outstanding53.95M96.07M
Employees4205,000
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Beta Bionics

BBNX stock →

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.

Health Care · Medical/Dental Instruments · 420 employees

About Lumexa Imaging

LMRI stock →

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.

Health Care · Medical Specialities · 5,000 employees

BBNX vs LMRI FAQ

Which is bigger, Beta Bionics or Lumexa Imaging?

Lumexa Imaging (LMRI) is larger, with a market capitalization of $1.01B compared with $951.07M for Beta Bionics (BBNX).

Are Beta Bionics and Lumexa Imaging in the same industry?

Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Beta Bionics and Medical Specialities for Lumexa Imaging.

More comparisons